We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A detailed guide on Truqap (capivasertib) dosage, how to take it, missed doses, and overdose information for breast cancer patients. Understand your treatment plan better.
Truqap, with its active ingredient capivasertib, is a vital prescription medication used in the treatment of a specific type of breast cancer. It belongs to a class of drugs known as kinase inhibitors, which play a crucial role in managing cancer cell growth. This guide aims to provide a clear and practical understanding of Truqap's dosage, how to take it, and important considerations for patients in India. It is essential to remember that this information is for educational purposes and should not replace the advice of your healthcare provider.
Truqap (capivasertib) is a targeted therapy drug. It works by inhibiting certain kinases, which are enzymes that help cancer cells grow and divide. By blocking these pathways, Truqap helps to slow down or stop the progression of breast cancer. It is particularly used for breast cancer that is HR-positive and HER2-negative, and has either spread locally or metastasized to other parts of the body. It is often used in combination with another medication called fulvestrant (Faslodex) when the cancer has progressed despite previous hormone therapy.
Truqap is available in tablet form and is taken orally. The typical recommended dosage for adults with HR-positive, HER2-negative advanced or metastatic breast cancer is 400 mg, taken twice daily. This dosage is administered on a specific schedule:
It is crucial to follow your doctor's instructions precisely when taking Truqap:
Missing a dose of Truqap can happen, and it's important to know how to manage it:
Truqap is available in two strengths: 160 milligrams (mg) and 200 mg. Your doctor will prescribe the specific dosage and strength that is appropriate for your condition and treatment plan. Do not adjust your dosage without consulting your doctor.
Taking more Truqap than prescribed can lead to harmful effects. It is critical to adhere strictly to the dosage prescribed by your doctor.
Truqap is typically used as a long-term treatment. The decision to continue treatment is based on whether it is safe and effective for your specific condition. Your doctor will regularly assess your response to the medication and discuss the ongoing treatment plan with you.
It is essential to maintain open communication with your healthcare team. Consult your doctor if:
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026